81_FR_68210 81 FR 68019 - National Cancer Institute; Notice of Closed Meetings

81 FR 68019 - National Cancer Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 191 (October 3, 2016)

Page Range68019-68020
FR Document2016-23734

Federal Register, Volume 81 Issue 191 (Monday, October 3, 2016) 
[Federal Register Volume 81, Number 191 (Monday, October 3, 2016)]
[Notices]
[Pages 68019-68020]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-23734]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Provocative Questions--PQ2.
    Date: October 20, 2016.
    Time: 12:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 6W030, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Zhiqiang Zou, MD, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, 9609 Medical Center Drive, Room 7W242, 
Rockville, MD 20892-9750, 240-276-6372, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Regional Centers of Research, Excellence in Non-Communicable 
Diseases in Low and Middle Income Countries.
    Date: October 25, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Shamala K. Srinivas, Ph.D., Scientific Review 
Officer, Office of Referral, Review and Program Coordination, Division 
of Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W530, Rockville, MD 20892-9750, 240-276-5856, 
[email protected]
    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Innovative Molecular Analysis Technologies (IMAT).
    Date: October 27-28, 2016.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Doubletree Hotel Bethesda, 8120 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: Reed A. Graves, Ph.D., Scientific Review Officer, 
Research and Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, 9609 Medical Center 
Drive, Room

[[Page 68020]]

7W264, Rockville, MD 20892-9750, 240-276-6384, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Provocative Questions--PQ4.
    Date: November 3, 2016.
    Time: 12:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical Center 
Drive, Room 7W032/034, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Zhiqiang Zou, MD, Ph.D., Scientific Review Officer, 
Special Review Branch, Division of Extramural Activities, National 
Cancer Institute, 9609 Medical Center Drive, Room 7W242, Rockville, MD 
20892-9750, 240-276-6372, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Fundamental Mechanisms of Affective and Decisional Process in 
Cancer Control.
    Date: November 4, 2016.
    Time: 11:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical Center 
Drive, Room 2W910, Rockville, MD 20850, (Telephone Conference Call).
    Contact Person: Thomas A. Winters, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, 9609 Medical Center Drive, Room 7W112, 
Rockville, MD 20892-9750, 240-276-6386, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Provocative Questions--PQ6.
    Date: November 4, 2016.
    Time: 12:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical Center 
Drive, Room 6W034, Rockville, MD 20850, (Telephone Conference Call).
    Contact Person: Zhiqiang Zou, MD, Ph.D., Scientific Review Officer, 
Special Review Branch, Division of Extramural Activities, National 
Cancer Institute, 9609 Medical Center Drive, Room 7W242, Rockville, MD 
20892-9750, 240-276-6372, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Provocative Questions--PQ8.
    Date: November 10, 2016.
    Time: 12:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical Center 
Drive, Room 7W032/034, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Yisong Wang, Ph.D., Scientific Review Officer, 
Special Review Branch, Division of Extramural Activities, National 
Cancer Institute, 9609 Medical Center Drive, Room 7W240, Rockville, MD 
20892-9750, 240-276-7157, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Provocative Questions in Cancer with an Underlying HIV 
Infection.
    Date: November 16, 2016.
    Time: 11:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical Center 
Drive, Room 4E030, Rockville, MD 20850, (Telephone Conference Call).
    Contact Person: Clifford W. Schweinfest, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, 9609 Medical Center Drive, Room 7W108, 
Rockville, MD 20892-9750, 240-276-6343, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: September 27, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-23734 Filed 9-30-16; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 81, No. 191 / Monday, October 3, 2016 / Notices 68019 in the survey is voluntary. Although the Board of Governors of the Federal Reserve The meetings will be closed to the names of the participating entities might System, September 28, 2016. public in accordance with the be disclosed in the summary memo and Robert deV. Frierson, provisions set forth in sections the memo might contain information Secretary of the Board. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., provided to the Board for internal use [FR Doc. 2016–23781 Filed 9–30–16; 8:45 am] as amended. The grant applications and only, exemption 4 of the Freedom of BILLING CODE 6210–01–P the discussions could disclose Information Act (5 U.S.C. 552(b)(4)) may confidential trade secrets or commercial exempt this information from disclosure property such as patentable material, to the public. However, if the and personal information concerning DEPARTMENT OF HEALTH AND individuals associated with the grant information collected on the FR 1374 HUMAN SERVICES does not meet these standards for applications, the disclosure of which confidentiality (for example if the Centers for Disease Control and would constitute a clearly unwarranted information collected is already public), Prevention invasion of personal privacy. it would not be granted confidential Name of Committee: National Cancer treatment. [CDC–2015–0034, Docket Number NIOSH Institute Special Emphasis Panel; NCI 233–A] Provocative Questions—PQ2. 2. Report title: Domestic Finance Date: October 20, 2016. Company Report of Consolidated Assets NIOSH List of Antineoplastic and Other Time: 12:00 p.m. to 5:00 p.m. and Liabilities. Hazardous Drugs in Healthcare Agenda: To review and evaluate grant Agency form number: FR 2248. Settings 2016 applications. Place: National Cancer Institute, Shady OMB control number: 7100–0005. AGENCY: National Institute for Grove, 9609 Medical Center Drive, Room Frequency: Monthly, quarterly, and Occupational Safety and Health 6W030, Rockville, MD 20850, (Telephone semi-annually. (NIOSH), Centers for Disease Control Conference Call). and Prevention (CDC), Department of Contact Person: Zhiqiang Zou, MD, Ph.D., Respondents: Domestic finance Health and Human Services (HHS). Scientific Review Officer, Special Review companies and mortgage companies. Branch, Division of Extramural Activities, ACTION: Notice of issuance of final National Cancer Institute, 9609 Medical Estimated number of respondents: guidance publication. Center Drive, Room 7W242, Rockville, MD 450. 20892–9750, 240–276–6372, zouzhiq@ Estimated average hours per response: SUMMARY: The National Institute for mail.nih.gov. Monthly, 20 minutes; Quarterly, 30 Occupational Safety and Health (NIOSH) of the Centers for Disease Name of Committee: National Cancer minutes; Addendum, 10 minutes. Institute Special Emphasis Panel; Control and Prevention (CDC), Estimated annual burden hours: 750 announces the availability of the Regional Centers of Research, hours. following publication: NIOSH List of Excellence in Non-Communicable General Description of Report: The FR Antineoplastic and Other Hazardous Diseases in Low and Middle Income 2248 is collected monthly as of the last Drugs in Healthcare Settings 2016 Countries. calendar day of the month from a [2016–161]. Date: October 25, 2016. stratified sample of finance companies. ADDRESSES: This document may be Time: 8:00 a.m. to 5:00 p.m. Each monthly report collects balance obtained at the following link: http:// Agenda: To review and evaluate grant sheet data on major categories of www.cdc.gov/niosh/docs/2016-161/. applications. consumer and business credit Place: Hyatt Regency Bethesda, One FOR FURTHER INFORMATION CONTACT: receivables and on major short-term Bethesda Metro Center, 7400 Wisconsin Barbara A. MacKenzie, NIOSH Division Avenue, Bethesda, MD 20814. liabilities. For quarter-end months of Applied Research and Technology, (March, June, September, and Contact Person: Shamala K. Srinivas, 1090 Tusculum Avenue, MS C–26, Ph.D., Scientific Review Officer, Office December), additional asset and liability Cincinnati, OH 45226. 513–533–8132 items are collected to provide a full of Referral, Review and Program (not a toll free number), bmackenzie@ Coordination, Division of Extramural balance sheet. A supplemental section cdc.gov. Activities, National Cancer Institute, collects data on securitized assets. The Dated: September 27, 2016. 9609 Medical Center Drive, Room data are used to construct universe Frank Hearl, 7W530, Rockville, MD 20892–9750, estimates of finance company holdings, Chief of Staff, National Institute for 240–276–5856, ss537t@nih.gov which are published in the monthly Occupational Safety and Health, Centers for Name of Committee: National Cancer statistical releases Finance Companies Disease Control and Prevention. Institute Special Emphasis Panel; (G.20) and Consumer Credit (G.19), in [FR Doc. 2016–23719 Filed 9–30–16; 8:45 am] Innovative Molecular Analysis the quarterly statistical release Flow of Technologies (IMAT). BILLING CODE 4163–19–P Funds Accounts of the United States Date: October 27–28, 2016. (Z.1), and in the Federal Reserve Time: 8:00 a.m. to 6:00 p.m. Bulletin (Tables 1.51, 1.52, and 1.55). DEPARTMENT OF HEALTH AND Agenda: To review and evaluate grant Legal authorization and HUMAN SERVICES applications. confidentiality: The Board’s Legal Place: Doubletree Hotel Bethesda, Division has determined that the FR National Institutes of Health 8120 Wisconsin Avenue, Bethesda, MD sradovich on DSK3GMQ082PROD with NOTICES 2248 is authorized by law pursuant to 20814. National Cancer Institute; Notice of Section 2A of the Federal Reserve Act, Contact Person: Reed A. Graves, Closed Meetings 12 U.S.C. 225a). The obligation to Ph.D., Scientific Review Officer, respond is voluntary. Individual Pursuant to section 10(d) of the Research and Technology and Contract respondent data are confidential under Federal Advisory Committee Act, as Review Branch, Division of Extramural section (b)(4) of the Freedom of amended (5 U.S.C. App.), notice is Activities, National Cancer Institute, Information Act (5 U.S.C. 552(b)(4)). hereby given of the following meetings. 9609 Medical Center Drive, Room VerDate Sep<11>2014 17:56 Sep 30, 2016 Jkt 241001 PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 E:\FR\FM\03OCN1.SGM 03OCN1

68020 Federal Register / Vol. 81, No. 191 / Monday, October 3, 2016 / Notices 7W264, Rockville, MD 20892–9750, Contact Person: Yisong Wang, Ph.D., Name of Committee: National Institute on 240–276–6384, gravesr@mail.nih.gov. Scientific Review Officer, Special Aging Special Emphasis Panel; Multi–Omics Review Branch, Division of Extramural in Osteoporosis. Name of Committee: National Cancer Activities, National Cancer Institute, Date: October 25, 2016. Institute Special Emphasis Panel; NCI Time: 1:00 p.m. to 5:00 p.m. Provocative Questions—PQ4. 9609 Medical Center Drive, Room Agenda: To review and evaluate grant Date: November 3, 2016. 7W240, Rockville, MD 20892–9750, applications. Time: 12:00 p.m. to 3:00 p.m. 240–276–7157, yisong.wang@nih.gov. Place: National Institute on Aging, Agenda: To review and evaluate grant Name of Committee: National Cancer Gateway Building, 2W200, 7201 Wisconsin applications. Institute Special Emphasis Panel; Avenue, Bethesda, MD 20892, (Telephone Place: National Cancer Institute, Provocative Questions in Cancer with Conference Call). Shady Grove, 9609 Medical Center an Underlying HIV Infection. Contact Person: Nijaguna Prasad, MS, Drive, Room 7W032/034, Rockville, MD Date: November 16, 2016. Ph.D., Scientific Review Officer, Scientific 20850, (Telephone Conference Call). Time: 11:00 a.m. to 4:00 p.m. Review Branch, National Institute of Aging, Contact Person: Zhiqiang Zou, MD, Agenda: To review and evaluate grant National Institutes of Health, Bethesda, MD Ph.D., Scientific Review Officer, Special 20892, 301–496–9667, nijaguna.prasad@ applications. nih.gov. Review Branch, Division of Extramural Place: National Cancer Institute, Activities, National Cancer Institute, Shady Grove, 9609 Medical Center (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, 9609 Medical Center Drive, Room Drive, Room 4E030, Rockville, MD National Institutes of Health, HHS) 7W242, Rockville, MD 20892–9750, 20850, (Telephone Conference Call). 240–276–6372, zouzhiq@mail.nih.gov. Contact Person: Clifford W. Dated: September 27, 2016. Name of Committee: National Cancer Schweinfest, Ph.D., Scientific Review Melanie J. Gray, Institute Special Emphasis Panel; Officer, Special Review Branch, Program Analyst, Office of Federal Advisory Fundamental Mechanisms of Affective Division of Extramural Activities, Committee Policy. and Decisional Process in Cancer National Cancer Institute, 9609 Medical [FR Doc. 2016–23735 Filed 9–30–16; 8:45 am] Control. Center Drive, Room 7W108, Rockville, BILLING CODE 4140–01–P Date: November 4, 2016. MD 20892–9750, 240–276–6343, Time: 11:00 a.m. to 4:00 p.m. schweinfestcw@mail.nih.gov. Agenda: To review and evaluate grant (Catalogue of Federal Domestic Assistance DEPARTMENT OF HEALTH AND applications. Program Nos. 93.392, Cancer Construction; HUMAN SERVICES Place: National Cancer Institute, 93.393, Cancer Cause and Prevention Shady Grove, 9609 Medical Center Research; 93.394, Cancer Detection and National Institutes of Health Drive, Room 2W910, Rockville, MD Diagnosis Research; 93.395, Cancer 20850, (Telephone Conference Call). Treatment Research; 93.396, Cancer Biology Notice of Correction for Research; 93.397, Cancer Centers Support; Announcement of Requirements and Contact Person: Thomas A. Winters, 93.398, Cancer Research Manpower; 93.399, Registration for ‘‘Antimicrobial Ph.D., Scientific Review Officer, Special Cancer Control, National Institutes of Health, Review Branch, Division of Extramural Resistance Rapid, Point-of-Need HHS) Activities, National Cancer Institute, Diagnostic Test’’ Challenge Dated: September 27, 2016. 9609 Medical Center Drive, Room The National Institutes of Health 7W112, Rockville, MD 20892–9750, Melanie J. Gray, Program Analyst, Office of Federal Advisory (NIH) is correcting a notice previously 240–276–6386, twinters@mail.nih.gov. published in the Federal Register on Committee Policy. Name of Committee: National Cancer September 8, 2016 (81 FR 62150), titled [FR Doc. 2016–23734 Filed 9–30–16; 8:45 am] Institute Special Emphasis Panel; NCI ‘‘Announcement of Requirements and BILLING CODE 4140–01–P Provocative Questions—PQ6. Registration for ‘Antimicrobial Date: November 4, 2016. Resistance Rapid, Point-of-Need Time: 12:00 p.m. to 4:00 p.m. Diagnostic Test’ Challenge.’’ The notice Agenda: To review and evaluate grant DEPARTMENT OF HEALTH AND HUMAN SERVICES announced the Antimicrobial Resistance applications. Place: National Cancer Institute, Rapid, Point-of-Need challenge Shady Grove, 9609 Medical Center National Institutes of Health competition that may result in the Drive, Room 6W034, Rockville, MD awarding of $20 million dollars for the National Institute on Aging; Notice of successful development of new, 20850, (Telephone Conference Call). Closed Meeting Contact Person: Zhiqiang Zou, MD, innovative, accurate, and cost-effective Ph.D., Scientific Review Officer, Special Pursuant to section 10(d) of the in vitro diagnostic tests that would Review Branch, Division of Extramural Federal Advisory Committee Act, as rapidly inform clinical treatment Activities, National Cancer Institute, amended (5 U.S.C. App.), notice is decisions and be of significant clinical 9609 Medical Center Drive, Room hereby given of the following meeting. and public health utility to combat the 7W242, Rockville, MD 20892–9750, The meeting will be closed to the development and spread of antibiotic 240–276–6372, zouzhiq@mail.nih.gov. public in accordance with the resistant bacteria and improve antibiotic provisions set forth in sections stewardship. Name of Committee: National Cancer Institute Special Emphasis Panel; NCI 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., The NIH is correcting and clarifying Provocative Questions—PQ8. as amended. The grant applications and several components of the Challenge the discussions could disclose competition including: sradovich on DSK3GMQ082PROD with NOTICES Date: November 10, 2016. Time: 12:00 p.m. to 5:00 p.m. confidential trade secrets or commercial (1) The letter of intent must be Agenda: To review and evaluate grant property such as patentable material, submitted by December 23, 2016, for all applications. and personal information concerning ‘‘Solvers’’ planning to submit for the Place: National Cancer Institute, individuals associated with the grant Step 1 (Theoretical) stage of the Shady Grove, 9609 Medical Center applications, the disclosure of which competition. The September 8, 2016 Drive, Room 7W032/034, Rockville, MD would constitute a clearly unwarranted announcement incorrectly stated that 20850, (Telephone Conference Call). invasion of personal privacy. the letter of intent prior to Step 1 was VerDate Sep<11>2014 17:56 Sep 30, 2016 Jkt 241001 PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 E:\FR\FM\03OCN1.SGM 03OCN1


Document Created: 2018-02-13 14:11:42
Document Modified: 2018-02-13 14:11:42
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesOctober 20, 2016.
FR Citation81 FR 68019 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR